Bladder CancerOCCURORTWNCT07088536
Occupational Situation and Return to Work of Urological Patients
An observational study of Bladder Cancer and Prostate Cancer, run by Jagiellonian University at 1 site in Poland.
Trial summary
This study will examine the work status of all adult patients admitted over a 6-month period to the University Hospital in Kraków, Poland, for treatment of urological diseases. All admitted patients will be surveyed about their job situation. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Bladder Cancer, Prostate Cancer, Renal Cancer
- What is being tested?
- Occupational Status Survey and Telephone Follow-up and Quality-of-Life Assessment in a subset of patients
- How many people
- 2,000 participants
- Where
- 1 sitePoland
- Study dates
- 21 Jul 2025to Apr 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Consecutive adult patients admitted over a 6-month period to the Department of Urology and Oncological Urology at the University Hospital in Kraków, an academic tertiary care center in Poland. As this is a uro-oncological department, patients with urological cancers are likely to be overrepresented. The population includes individuals hospitalized for a range of urological diseases, with a subset of occupationally active patients undergoing major uro-oncological surgeries or procedures for urinary tract stones. Participants represent a typical tertiary referral population treated for both malignant and benign urological conditions.
Who may be able to join
- Adult patients (≥18 years) admitted to the Department of Urology and Oncological Urology, University Hospital in Kraków, during the 6-month study period.
- For the prospective follow-up cohort:
- Occupationally active (employed) at baseline.
- Undergoing major uro-oncological surgery (e.g., radical cystectomy, radical prostatectomy, nephrectomy) or a procedure for urinary tract stones (e.g., ureterorenoscopy, percutaneous nephrolithotripsy).
- Able and willing to provide written informed consent.
Who cannot join
- Patients unwilling or unable to provide informed consent.
- Patients who are unemployed or retired at baseline (excluded from the prospective follow-up cohort but included in the baseline cross-sectional survey).
- Patients not undergoing major uro-oncological surgery or urinary tract stone procedures (for the prospective follow-up cohort).
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Poland1 site, 1 recruiting
- Recruiting
Jagiellonian University Medical College
Krakow, Malopolska, 30-688
Principal Investigator, +48124002500, aka.czech@uj.edu.pl
About this study
Official title: Occupational Situation of Patients With Urological Diseases and Return to Work in Patients Undergoing Major Uro-Oncological Operations and Procedures for Urinary Tract Stones
This study will examine the work status of all adult patients admitted over a 6-month period to the University Hospital in Kraków, Poland, for treatment of urological diseases. All admitted patients will be surveyed about their job situation. Patients who are occupationally active and undergoing major oncological surgeries (such as radical cystectomy, prostatectomy, or nephrectomy) or procedures for urinary tract stones will also complete a quality-of-life questionnaire and be followed up by phone at 3 and 6 months. The goal is to learn how treatment affects patients' ability to return to work and their well-being, to help guide support and rehabilitation strategies.
- Conditions
- Bladder Cancer, Prostate Cancer, Renal Cancer, Urinary Stones
- Being tested
- Occupational Status Survey and Telephone Follow-up and Quality-of-Life Assessment in a subset of patients
- Medical subject headings
- Urinary Bladder Neoplasms, Prostatic Neoplasms, Kidney Neoplasms, Urinary Calculi
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Occupational Status Survey and Telephone Follow-up and Quality-of-Life Assessment in a subset of patientsOther
Collection of demographic, employment, and clinical data at hospital admission, with additional EQ-5D-5L quality-of-life questionnaire and telephone follow-up for occupationally active patients undergoing major uro-oncological surgeries or urinary tract stone procedures.
| Study group | Role | What they receive |
|---|---|---|
| Patients admitted to the Department of Urology and Oncological Urology over a 6-month period | Adult patients (≥18 years) admitted over a 6-month period to the Department of Urology and Oncological Urology, University Hospital in Kraków, Poland, including a subset of occupationally active individuals undergoing major uro-oncological surgeries or procedures for urinary tract stones. Receives: Other: Occupational Status Survey and Telephone Follow-up and Quality-of-Life Assessment in a subset of patients |
What is being measured
The primary outcome is the main question the study is designed to answer.
Occupational Status of Patients With Urological Diseases
Descriptive assessment of employment categories (employed, unemployed, on disability, retired) among all admitted patients, and changes in employment status over time for occupationally active patients undergoing major surgeries or stone-related procedures.
Measured: At hospital admission (baseline), and at 3 and 6 months for the prospective cohort
Return to Work Rate in Occupationally Active Patients Undergoing Major Uro-Oncological Surgeries
Proportion of employed patients at baseline who resume or maintain work following radical cystectomy, radical prostatectomy, radical or partial nephrectomy, or nephroureterectomy.
Measured: 3 months and 6 months after surgery
Return to Work Rate in Occupationally Active Patients Undergoing Procedures for Urinary Tract Stones
Proportion of employed patients at baseline who resume or maintain work following ureterorenoscopy or percutaneous nephrolithotripsy.
Measured: 3 months and 6 months after procedure
Secondary outcomes (2)
Change in Quality of Life in Occupationally Active Patients Undergoing Major Uro-Oncological Surgeries (EQ-5D-5L Score)
Measured: Baseline, 3 months, and 6 months
Change in Quality of Life in Occupationally Active Patients Undergoing Procedures for Urinary Tract Stones (EQ-5D-5L Score)
Measured: Baseline, 3 months, and 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Jul 2025
- Study start21 Jul 2025
- Primary completionDec 2026 (estimated)
- Study completionApr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Bladder CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 2,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Jagiellonian University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Anna K. Czech, MD, Jagiellonian University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07088536
- Sponsor's protocol ID
- OCC-URO-RTW-ONCO-LITH
- Acronym
- OCCURORTW
- Status last verified
- Mar 2026
- First submitted
- 20 Jul 2025
- Last updated
- 3 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 3 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Occupational Situation of Patients With Urological Diseases and Return to Work in Patients Undergoing Major Uro-Oncological Operations and Procedures for Urinary Tract Stones
- ClinicalTrials.gov ID
- NCT07088536
- Acronym / sponsor ID
- OCCURORTW / OCC-URO-RTW-ONCO-LITH
- Conditions
- Bladder Cancer, Prostate Cancer, Renal Cancer, Urinary Stones
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 2,000 participants (estimated)
- Lead sponsor
- Jagiellonian UniversityUniversity, hospital or other
- Study start
- 21 Jul 2025 (actual)
- Primary completion
- Dec 2026 (estimated)
- Study completion
- Apr 2027 (estimated)
- First posted
- 28 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will examine the work status of all adult patients admitted over a 6-month period to the University Hospital in Kraków, Poland, for treatment of urological diseases. All admitted patients will be surveyed about their job situation. Patients who are occupationally active and undergoing major oncological surgeries (such as radical cystectomy, prostatectomy, or nephrectomy) or procedures for urinary tract stones will also complete a quality-of-life questionnaire and be followed up by phone at 3 and 6 months. The goal is to learn how treatment affects patients' ability to return to work and their well-being, to help guide support and rehabilitation strategies.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients admitted to the Department of Urology and Oncological Urology over a 6-month period | – | Other: Occupational Status Survey and Telephone Follow-up and Quality-of-Life Assessment in a subset of patientsAdult patients (≥18 years) admitted over a 6-month period to the Department of Urology and Oncological Urology, University Hospital in Kraków, Poland, including a subset of occupationally active individuals undergoing major uro-oncological surgeries or procedures for urinary tract stones. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Consecutive adult patients admitted over a 6-month period to the Department of Urology and Oncological Urology at the University Hospital in Kraków, an academic tertiary care center in Poland. As this is a uro-oncological department, patients with urological cancers are likely to be overrepresented. The population includes individuals hospitalized for a range of urological diseases, with a subset of occupationally active patients undergoing major uro-oncological surgeries or procedures for urinary tract stones. Participants represent a typical tertiary referral population treated for both malignant and benign urological conditions.
Key inclusion criteria (5 listed)
- Adult patients (≥18 years) admitted to the Department of Urology and Oncological Urology, University Hospital in Kraków, during the 6-month study period.
- For the prospective follow-up cohort:
- Able and willing to provide written informed consent.
Key exclusion criteria (3 listed)
- Patients unwilling or unable to provide informed consent.
- Patients who are unemployed or retired at baseline (excluded from the prospective follow-up cohort but included in the baseline cross-sectional survey).
- Patients not undergoing major uro-oncological surgery or urinary tract stone procedures (for the prospective follow-up cohort).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Occupational Status Survey and Telephone Follow-up and Quality-of-Life Assessment in a subset of patientsCollection of demographic, employment, and clinical data at hospital admission, with additional EQ-5D-5L quality-of-life questionnaire and telephone follow-up for occupationally active patients undergoing major uro-oncological surgeries or urinary tract stone procedures. | Other | Patients admitted to the Department of Urology and Oncological Urology over a 6-month period |
Primary outcome
Occupational Status of Patients With Urological Diseases
Time frame: At hospital admission (baseline), and at 3 and 6 months for the prospective cohort
Descriptive assessment of employment categories (employed, unemployed, on disability, retired) among all admitted patients, and changes in employment status over time for occupationally active patients undergoing major surgeries or stone-related procedures.
Return to Work Rate in Occupationally Active Patients Undergoing Major Uro-Oncological Surgeries
Time frame: 3 months and 6 months after surgery
Proportion of employed patients at baseline who resume or maintain work following radical cystectomy, radical prostatectomy, radical or partial nephrectomy, or nephroureterectomy.
Return to Work Rate in Occupationally Active Patients Undergoing Procedures for Urinary Tract Stones
Time frame: 3 months and 6 months after procedure
Proportion of employed patients at baseline who resume or maintain work following ureterorenoscopy or percutaneous nephrolithotripsy.
2 secondary outcomes
Change in Quality of Life in Occupationally Active Patients Undergoing Major Uro-Oncological Surgeries (EQ-5D-5L Score)
Time frame: Baseline, 3 months, and 6 months
Change in Quality of Life in Occupationally Active Patients Undergoing Procedures for Urinary Tract Stones (EQ-5D-5L Score)
Time frame: Baseline, 3 months, and 6 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Mar 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Bladder Cancer
Active, not recruitingEarly Phase 1
(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer
Bladder Cancer
Not yet recruitingObservational study
Outcomes for IR and High Risk (HR) Non-muscle Invasive Bladder Cancer (NMIBC) and ctDNA-based Biomarkers for Response and Recurrence in Muscle Invasive Bladder Cancer (MIBC)
NMIBC, MIBC
RecruitingPhase 2/3
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Active, not recruitingPhase 2
Intravesical Gem/Doce in Patients With NMIBC
Urinary Bladder Cancer
Active, not recruitingPhase 3
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Bladder Cancer and Prostate Cancer, run by Jagiellonian University at 1 site in Poland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 3 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Anna K. Czech, M.D., Ph.D. (+48124002500, aka.czech@uj.edu.pl), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Occupational Status of Patients With Urological Diseases (time frame: At hospital admission (baseline), and at 3 and 6 months for the prospective cohort). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2026.